Acesso livre
Acesso livre

Gastroenterologia

Diretriz de consenso | Ação diagnóstica contra a hipertransaminasemia em pediatria.

13 Jun, 2022 | 14:50h

Diagnostic action against hypertransaminasemia in paediatrics: Consensus document of Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica (SEGHNP), Asociación Española de Pediatría de Atención Primaria (AEPap) and Sociedad Española de Pediatría de Atención Primaria (SEPEAP) – Anales de Pediatría (English Edition)


Estudo randomizado | Dispositivo assistido por computador melhora a detecção de adenomas na colonoscopia para rastreamento e vigilância.

13 Jun, 2022 | 14:34h

Computer-Aided Detection Improves Adenomas per Colonoscopy for Screening and Surveillance Colonoscopy: A Randomized Trial – Gastroenterology

Comentário: Colonoscopy With a Computer-Aided Device Boosted Adenoma Detection — Use of the device led to a 27% increase in adenomas per colonoscopy versus standard procedure – MedPage Today (necessário cadastro gratuito)


Revisão | Patogênese da doença hepática associada ao álcool.

13 Jun, 2022 | 14:25h

Pathogenesis of Alcohol-Associated Liver Disease – Journal of Clinical and Experimental Hepatology


Diretrizes para tratamento da infecção por Clostridioides (Clostridium) difficile.

13 Jun, 2022 | 14:07h

Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection – Journal of Infection and Chemotherapy


Consenso sobre o diagnóstico e o tratamento da alergia à proteína do leite de vaca.

6 Jun, 2022 | 11:22h

Consensus on the diagnosis and treatment of cow’s milk protein allergy of the Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition – Revista de Gastroenterología de México (English Edition)


Estudo de coorte retrospectiva | Vigilância por colonoscopia após remoção de adenoma para reduzir o risco de câncer colorretal.

2 Jun, 2022 | 13:46h

Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study – Health Technology Assessment


Metanálise de estudos com mais de 10 anos de seguimento | Impacto de longo prazo da terapia de erradicação do Helicobacter pylori sobre a incidência de câncer gástrico e mortalidade em indivíduos saudáveis infectados.

1 Jun, 2022 | 13:56h

Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: A meta-analysis beyond 10 years of follow-up – Gastroenterology

 

Comentário do autor no Twitter (fio – clique para saber mais)

 


Investigação da hepatite aguda de origem desconhecida em crianças.

31 Mai, 2022 | 12:27h

Investigating Acute Hepatitis of Unknown Origin in Children – American Society for Microbiology

Conteúdos relacionados:

What’s sending kids to hospitals with hepatitis—coronavirus, adenovirus, or both? – Science

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing 3 – UK Health Security Agency

Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years – Eurosurveillance

Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022 – Eurosurveillance

Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens – The Lancet Gastroenterology & Hepatology

Puzzling pediatric hepatitis cases echo an earlier mysterious illness – STAT

Why COVID is a key suspect in severe hepatitis cases in kids worldwide – CBC

Hepatitis outbreak in children: What do we know so far? – Imperial College London

Explaining the unexplained hepatitis in children – The Lancet Infectious Diseases

Epidemiological update: Hepatitis of unknown aetiology in children – European Centre for Disease Prevention and Control

Unexplained hepatitis cases in kids rise to 348 in 20 nations – CIDRAP

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing 2 – UK Health Security Agency

With usual suspects ruled out, disease detectives try to crack mystery of viral hepatitis cases in kids – STAT

Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022 – Morbidity and Mortality Weekly Report

The CDC and WHO Have Reported an Unusual Cluster of Severe Pediatric Hepatitis Cases – Science-Based Medicine

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing – UK Health Security Agency

Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization

WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT

CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press

 

Comentário no Twitter

 


Índice de gravidade clínica para esofagite eosinofílica: desenvolvimento, consenso e direções futuras.

31 Mai, 2022 | 12:23h

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions – Gastroenterology

 

Comentário no Twitter

 


Estudo randomizado | Risankizumabe como terapia de manutenção para doença de Crohn gravemente ativa.

31 Mai, 2022 | 12:13h

Risankizumab as maintenance therapy for moderately to severely active Crohn’s disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial – The Lancet (link para o resumo – $ para o texto completo)


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.